4//SEC Filing
Versant Vantage I, L.P. 4
Accession 0000899243-20-031771
CIK 0001701541other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 9:19 PM ET
Size
20.9 KB
Accession
0000899243-20-031771
Insider Transaction Report
Form 4
Versant Voyageurs I, L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-11-17$33.05/sh−489$16,161→ 984,180 total(indirect: See Footnote) - Sale
Common Stock
2020-11-17$33.05/sh−3,705$122,450→ 4,933,927 total - Sale
Common Stock
2020-11-18$33.09/sh−63$2,085→ 984,117 total(indirect: See Footnote) - Sale
Common Stock
2020-11-18$33.09/sh−473$15,653→ 4,933,454 total
Holdings
- 1,432,212(indirect: See Footnote)
Common Stock
- 427,063(indirect: See Footnote)
Common Stock
Versant Vantage I, L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-11-17$33.05/sh−489$16,161→ 984,180 total(indirect: See Footnote) - Sale
Common Stock
2020-11-17$33.05/sh−3,705$122,450→ 4,933,927 total - Sale
Common Stock
2020-11-18$33.09/sh−63$2,085→ 984,117 total(indirect: See Footnote) - Sale
Common Stock
2020-11-18$33.09/sh−473$15,653→ 4,933,454 total
Holdings
- 1,432,212(indirect: See Footnote)
Common Stock
- 427,063(indirect: See Footnote)
Common Stock
Versant Venture Capital VI, L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-11-17$33.05/sh−489$16,161→ 984,180 total(indirect: See Footnote) - Sale
Common Stock
2020-11-17$33.05/sh−3,705$122,450→ 4,933,927 total - Sale
Common Stock
2020-11-18$33.09/sh−63$2,085→ 984,117 total(indirect: See Footnote) - Sale
Common Stock
2020-11-18$33.09/sh−473$15,653→ 4,933,454 total
Holdings
- 427,063(indirect: See Footnote)
Common Stock
- 1,432,212(indirect: See Footnote)
Common Stock
Versant Voyageurs I Parallel, L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-11-17$33.05/sh−3,705$122,450→ 4,933,927 total - Sale
Common Stock
2020-11-18$33.09/sh−473$15,653→ 4,933,454 total - Sale
Common Stock
2020-11-17$33.05/sh−489$16,161→ 984,180 total(indirect: See Footnote) - Sale
Common Stock
2020-11-18$33.09/sh−63$2,085→ 984,117 total(indirect: See Footnote)
Holdings
- 427,063(indirect: See Footnote)
Common Stock
- 1,432,212(indirect: See Footnote)
Common Stock
Footnotes (7)
- [F1]The sale of these shares were effected pursuant to Rule 10b5-1 trading plans adopted by each of Versant Vantage I, L.P. ("Versant Vantage I") and Versant Venture Capital VI, L.P. ("Versant VI"), respectively.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
- [F3]Shares held by Versant Vantage I. Versant Vantage I GP, L.P. ("Versant Vantage I GP LP") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC ("Versant Vantage I GP-GP") is the general partner of Versant Vantage I GP LP. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports.
- [F4]Shares held by Versant VI. Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.025 to $33.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4.
- [F6]Shares held by Versant Voyageurs I, L.P. ("Versant Voyageurs I"). Versant Voyageurs I GP Company ("Versant Voyageurs I GP") is the general partner of Versant Voyageurs I. Bradley J. Bolzon may be deemed to share voting and dispositive power over the shares held by Versant Voyageurs I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports.
- [F7]Shares held by Versant Voyageurs I Parallel, L.P. ("Versant I Parallel"). Versant Voyageurs I GP, L.P. ("Versant Voyageurs I GP LP") is the general partner of Versant I Parallel. Versant Ventures VI GP is the general partner of Versant Voyageurs I GP LP. Versant Ventures VI GP-GP is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant I Parallel; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports.
Documents
Issuer
Black Diamond Therapeutics, Inc.
CIK 0001701541
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001765253
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 9:19 PM ET
- Size
- 20.9 KB